Author:
Xu Su-Wei,Law Betty Yuen Kwan,Qu Steven Li Qun,Hamdoun Sami,Chen Juan,Zhang Wei,Guo Jian-Ru,Wu An-Guo,Mok Simon Wing Fai,Zhang David Wei,Xia Chenglai,Sugimoto Yoshikazu,Efferth Thomas,Liu Liang,Wong Vincent Kam Wai
Funder
Macao Science and Technology Development Fund
Foshan Medicine Dengfeng Project of China
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Natural small-molecules reverse Xeroderma Pigmentosum Complementation Group C (XPC) deficient-mediated drug-resistance in renal cell carcinoma;Phytomedicine;2024-02
2. (2R,4aS,6aS,12bR,14aS,14bR)10-Hydroxy-N-(4-((6-methoxyquinolin-8-yl)amino)pentyl)-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxamide;Molbank;2023-08-29
3. Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review);International Journal of Oncology;2023-08-28
4. A non-drug chemotherapy-like synergizes with gas-/immunotherapy based on cancer cell membrane camouflage-functionalized nanoplatform;Nano Today;2023-08
5. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies;Biomedicine & Pharmacotherapy;2023-07